Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07832942 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Beta-2 Adrenergic Receptor Polymorphic Variants: An Endotype of Salt Sensitive Hypertension (Beta2AR).

Study acronym: Beta2AR
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-11
View on ClinicalTrials.gov ↗
All living things are made of building blocks called cells. Genes are the part of cells that contain the instructions which determine important things about you, like your height or hair color, and affect your health. DNA is the material in the cells that makes up your genes and your particular make-up is call your genotype. Changes or differences in a gene (your genotype) may affect your chances of developing a particular disease, or how a person responds to a particular drug. Your genes are passed down from your parents and then passed on to your children. Different forms of certain genes in your body, for example, the B2AR gene, can increase your blood pressure. The form of the gene that could raise your blood pressure is called the risk allele or risk genotype. Taking too much salt in your food or drink also can increase your blood pressure. In this research study we want to determine if different forms of the B2AR gene and the level of salt intake act together to cause high blood pressure.
Trial Details
NCT Number NCT07832942
Lead Sponsor Brigham and Women's Hospital
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Genetics in Hypertension
Enrollment 110 participants
Start Date 2026-11
Primary Completion 2030-04 (estimated)
Study Completion 2030-04 (estimated)
Updated on ClinicalTrials.gov 2026-09-22